BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 28785836)

  • 21. Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper.
    Randall LM; Pothuri B; Swisher EM; Diaz JP; Buchanan A; Witkop CT; Bethan Powell C; Smith EB; Robson ME; Boyd J; Coleman RL; Lu K
    Gynecol Oncol; 2017 Aug; 146(2):217-224. PubMed ID: 28596016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increasing genetic counseling referral rates through bundled interventions after ovarian cancer diagnosis.
    Swanson CL; Kumar A; Maharaj JM; Kemppainen JL; Thomas BC; Weinhold MR; Slaby KM; Mara KC; Wick MJ; Bakkum-Gamez JN
    Gynecol Oncol; 2018 Apr; 149(1):121-126. PubMed ID: 29402500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients.
    Lumish HS; Steinfeld H; Koval C; Russo D; Levinson E; Wynn J; Duong J; Chung WK
    J Genet Couns; 2017 Oct; 26(5):1116-1129. PubMed ID: 28357778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer.
    Jacobs AS; Schwartz MD; Valdimarsdottir H; Nusbaum RH; Hooker GW; DeMarco TA; Heinzmann JE; McKinnon W; McCormick SR; Davis C; Forman AD; Lebensohn AP; Dalton E; Tully DM; Graves KD; Similuk M; Kelly S; Peshkin BN
    Fam Cancer; 2016 Oct; 15(4):529-39. PubMed ID: 26969308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic counseling, testing, and screening for breast and ovarian cancer: practical and social considerations.
    Khabele D; Runowicz CD
    Curr Womens Health Rep; 2002 Jun; 2(3):163-9. PubMed ID: 12099190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Missed therapeutic and prevention opportunities in women with BRCA-mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature.
    Hoskins PJ; Gotlieb WH
    CA Cancer J Clin; 2017 Nov; 67(6):493-506. PubMed ID: 28881380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What women with ovarian cancer think and know about genetic testing.
    Lacour RA; Daniels MS; Westin SN; Meyer LA; Burke CC; Burns KA; Kurian S; Webb NF; Pustilnik TB; Lu KH
    Gynecol Oncol; 2008 Oct; 111(1):132-6. PubMed ID: 18684498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic consultation embedded in a gynecologic oncology clinic improves compliance with guideline-based care.
    Senter L; O'Malley DM; Backes FJ; Copeland LJ; Fowler JM; Salani R; Cohn DE
    Gynecol Oncol; 2017 Oct; 147(1):110-114. PubMed ID: 28800943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A self-administered family history questionnaire improves identification of women who warrant referral to genetic counseling for hereditary cancer risk.
    Vogel TJ; Stoops K; Bennett RL; Miller M; Swisher EM
    Gynecol Oncol; 2012 Jun; 125(3):693-8. PubMed ID: 22446623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modified panel-based genetic counseling for ovarian cancer susceptibility: A randomized non-inferiority study.
    McCuaig JM; Tone AA; Maganti M; Romagnuolo T; Ricker N; Shuldiner J; Rodin G; Stockley T; Kim RH; Bernardini MQ
    Gynecol Oncol; 2019 Apr; 153(1):108-115. PubMed ID: 30638766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does the diagnosis of breast or ovarian cancer trigger referral to genetic counseling?
    Powell CB; Littell R; Hoodfar E; Sinclair F; Pressman A
    Int J Gynecol Cancer; 2013 Mar; 23(3):431-6. PubMed ID: 23354368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positive experiences of healthcare professionals with a mainstreaming approach of germline genetic testing for women with ovarian cancer.
    Bokkers K; Zweemer RP; Koudijs MJ; Stehouwer S; Velthuizen ME; Bleiker EMA; Ausems MGEM
    Fam Cancer; 2022 Jul; 21(3):295-304. PubMed ID: 34617209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of communicating uncertain test results in cancer genetic counseling: A systematic mixed studies review.
    Medendorp NM; van Maarschalkerweerd PEA; Murugesu L; Daams JG; Smets EMA; Hillen MA
    Patient Educ Couns; 2020 Sep; 103(9):1692-1708. PubMed ID: 32278626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disseminating universal genetic testing to a diverse, indigent patient population at a county hospital gynecologic oncology clinic.
    Bednar EM; Sun CC; Camacho B; Terrell J; Rieber AG; Ramondetta LM; Freedman RS; Lu KH
    Gynecol Oncol; 2019 Feb; 152(2):328-333. PubMed ID: 30528888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A preliminary investigation of genetic counselors' information needs when receiving a variant of uncertain significance result: a mixed methods study.
    Scherr CL; Lindor NM; Malo TL; Couch FJ; Vadaparampil ST
    Genet Med; 2015 Sep; 17(9):739-46. PubMed ID: 25569439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FDA Approval of PARP Inhibitors and the Impact on Genetic Counseling and Genetic Testing Practices.
    Buchtel KM; Vogel Postula KJ; Weiss S; Williams C; Pineda M; Weissman SM
    J Genet Couns; 2018 Feb; 27(1):131-139. PubMed ID: 28780754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MAGENTA (Making Genetic testing accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing.
    Rayes N; Bowen DJ; Coffin T; Nebgen D; Peterson C; Munsell MF; Gavin K; Lechner R; Crase J; Polinsky D; Romero I; Blank SV; Levine DA; Norquist BM; Swisher EM; Lu KH
    BMC Cancer; 2019 Jul; 19(1):648. PubMed ID: 31266460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity management in gynecologic cancer survivors: provider practices and attitudes.
    Jernigan AM; Tergas AI; Satin AJ; Fader AN
    Am J Obstet Gynecol; 2013 May; 208(5):408.e1-8. PubMed ID: 23395643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic risk assessment for women with epithelial ovarian cancer: referral patterns and outcomes in a university gynecologic oncology clinic.
    Petzel SV; Vogel RI; Bensend T; Leininger A; Argenta PA; Geller MA
    J Genet Couns; 2013 Oct; 22(5):662-73. PubMed ID: 23677535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Referral of Ovarian Cancer Patients for Genetic Counselling by Oncologists: Need for Improvement.
    Ricci MT; Sciallero S; Mammoliti S; Gismondi V; Franiuk M; Bruzzi P; Varesco L
    Public Health Genomics; 2015; 18(4):225-32. PubMed ID: 26111740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.